Your browser doesn't support javascript.
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.
Flament, Héloïse; Rouland, Matthieu; Beaudoin, Lucie; Toubal, Amine; Bertrand, Léo; Lebourgeois, Samuel; Rousseau, Camille; Soulard, Pauline; Gouda, Zouriatou; Cagninacci, Lucie; Monteiro, Antoine C; Hurtado-Nedelec, Margarita; Luce, Sandrine; Bailly, Karine; Andrieu, Muriel; Saintpierre, Benjamin; Letourneur, Franck; Jouan, Youenn; Si-Tahar, Mustapha; Baranek, Thomas; Paget, Christophe; Boitard, Christian; Vallet-Pichard, Anaïs; Gautier, Jean-François; Ajzenberg, Nadine; Terrier, Benjamin; Pène, Frédéric; Ghosn, Jade; Lescure, Xavier; Yazdanpanah, Yazdan; Visseaux, Benoit; Descamps, Diane; Timsit, Jean-François; Monteiro, Renato C; Lehuen, Agnès.
  • Flament H; Laboratory of Immunological Dysfunction, Assistance Publique-Hôpitaux de Paris (AP-HP), Bichat-Claude Bernard University Hospital, Paris, France.
  • Rouland M; Université de Paris, Center for Research on Inflammation, Inserm U1149 & CNRS ERL8252, Inflamex Laboratory, Paris, France.
  • Beaudoin L; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Toubal A; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Bertrand L; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Lebourgeois S; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Rousseau C; Department of Virology, AP-HP, Bichat-Claude Bernard University Hospital, Paris, France.
  • Soulard P; Université de Paris, Infections Antimicrobials Modelling Evolution UMR 1137, Paris, France.
  • Gouda Z; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Cagninacci L; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Monteiro AC; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Hurtado-Nedelec M; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Luce S; Department of Virology, AP-HP, Bichat-Claude Bernard University Hospital, Paris, France.
  • Bailly K; Université de Paris, Infections Antimicrobials Modelling Evolution UMR 1137, Paris, France.
  • Andrieu M; Laboratory of Immunological Dysfunction, Assistance Publique-Hôpitaux de Paris (AP-HP), Bichat-Claude Bernard University Hospital, Paris, France.
  • Saintpierre B; Université de Paris, Center for Research on Inflammation, Inserm U1149 & CNRS ERL8252, Inflamex Laboratory, Paris, France.
  • Letourneur F; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Jouan Y; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Si-Tahar M; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Baranek T; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Paget C; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Boitard C; Université de Tours, Inserm, Centre d'Etude des Pathologies Respiratoires UMR 1100, Tours, France.
  • Vallet-Pichard A; Intensive Care Medical Unit, Tours Regional University Hospital, Tours, France.
  • Gautier JF; Université de Tours, Inserm, Centre d'Etude des Pathologies Respiratoires UMR 1100, Tours, France.
  • Ajzenberg N; Université de Tours, Inserm, Centre d'Etude des Pathologies Respiratoires UMR 1100, Tours, France.
  • Terrier B; Université de Tours, Inserm, Centre d'Etude des Pathologies Respiratoires UMR 1100, Tours, France.
  • Pène F; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Ghosn J; Department of Diabetology, AP-HP, Cochin University Hospital, Paris, France.
  • Lescure X; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
  • Yazdanpanah Y; Department of Hepatology, AP-HP, Cochin University Hospital, Paris, France.
  • Visseaux B; Department of Diabetes and Endocrinology, AP-HP, Lariboisière Hospital, Paris, France.
  • Descamps D; Department of Hematology, AP-HP, Bichat-Claude Bernard University Hospital, Paris, France.
  • Timsit JF; Université de Paris, LVTS, Inserm, Paris, France.
  • Monteiro RC; Department of Internal Medicine, AP-HP, Cochin University Hospital, Paris, France.
  • Lehuen A; Université de Paris, Institut Cochin, Inserm U1016, Centre National de la Recherche Scientifique UMR 8104, Inflamex Laboratory, Paris, France.
Nat Immunol ; 22(3): 322-335, 2021 03.
Article in English | MEDLINE | ID: covidwho-1060966
ABSTRACT
Immune system dysfunction is paramount in coronavirus disease 2019 (COVID-19) severity and fatality rate. Mucosal-associated invariant T (MAIT) cells are innate-like T cells involved in mucosal immunity and protection against viral infections. Here, we studied the immune cell landscape, with emphasis on MAIT cells, in cohorts totaling 208 patients with various stages of disease. MAIT cell frequency is strongly reduced in blood. They display a strong activated and cytotoxic phenotype that is more pronounced in lungs. Blood MAIT cell alterations positively correlate with the activation of other innate cells, proinflammatory cytokines, notably interleukin (IL)-18, and with the severity and mortality of severe acute respiratory syndrome coronavirus 2 infection. We also identified a monocyte/macrophage interferon (IFN)-α-IL-18 cytokine shift and the ability of infected macrophages to induce the cytotoxicity of MAIT cells in an MR1-dependent manner. Together, our results suggest that altered MAIT cell functions due to IFN-α-IL-18 imbalance contribute to disease severity, and their therapeutic manipulation may prevent deleterious inflammation in COVID-19 aggravation.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Monocytes / Interferon-alpha / Interleukin-18 / Mucosal-Associated Invariant T Cells / COVID-19 / Macrophages Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Animals / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: Nat Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: S41590-021-00870-z

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Monocytes / Interferon-alpha / Interleukin-18 / Mucosal-Associated Invariant T Cells / COVID-19 / Macrophages Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Animals / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: Nat Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: S41590-021-00870-z